Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
News
- Nature Communications: Multifaceted roles of PDS5B in RAD51-dependent homology-directed DNA repair and replication fork protection (Sung, Rao, Olsen, Wasmuth, Zhao, Libich)
- India Post: Manjeet Rao, PhD Recognized as “Indian American Cancer Scientists Honored with Prestigious SAASCR Awards for Pioneering Breakthroughs” (Rao)
- Recognizing Excellence in Radiation Research: Dr. Weixing Zhao Named Michael Fry Award Recipient
- Panneerdoss Subbarayalu, PhD (Rao Lab) to Receive $879,000 American Cancer Society Grant
- What if we could stop chronic pain before it starts? (Lai Lab)
Events
Greehey CCRI Seminar Series: Dima Kozakov, PhD (UT Austin)
Presentation title: “Modeling and modulating disease at systems level with physics aware deep learning”
Greehey CCRI Spring ’26 Seminar Series: Reuben Harris, PhD (UTHSA)
Presentation title: “Progress on the development of novel drugs for viral proteases”